Your browser is no longer supported. Please, upgrade your browser.
Settings
CPRX Catalyst Pharmaceuticals, Inc. daily Stock Chart
CPRX [NASD]
Catalyst Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.12 Insider Own4.60% Shs Outstand101.67M Perf Week-11.98%
Market Cap664.92M Forward P/E11.43 EPS next Y0.57 Insider Trans0.54% Shs Float95.82M Perf Month9.36%
Income-12.00M PEG- EPS next Q0.10 Inst Own61.40% Short Float7.43% Perf Quarter74.40%
Sales41.80M P/S15.91 EPS this Y-54.40% Inst Trans2.64% Short Ratio4.15 Perf Half Y62.69%
Book/sh0.62 P/B10.55 EPS next Y86.32% ROA-18.00% Target Price9.33 Perf Year105.02%
Cash/sh0.59 P/C11.10 EPS next 5Y- ROE-21.00% 52W Range1.85 - 7.67 Perf YTD240.63%
Dividend- P/FCF- EPS past 5Y-4.40% ROI-69.50% 52W High-14.73% Beta2.36
Dividend %- Quick Ratio5.10 Sales past 5Y- Gross Margin85.70% 52W Low253.51% ATR0.48
Employees51 Current Ratio5.10 Sales Q/Q- Oper. Margin- RSI (14)58.71 Volatility10.31% 6.96%
OptionableYes Debt/Eq0.00 EPS Q/Q278.00% Profit Margin-28.80% Rel Volume1.27 Prev Close6.54
ShortableYes LT Debt/Eq0.00 EarningsAug 07 AMC Payout- Avg Volume1.71M Price6.54
Recom- SMA203.36% SMA5020.39% SMA20065.18% Volume0 Change0.00%
Sep-21-18Initiated Cantor Fitzgerald Overweight
Sep-07-18Resumed Piper Jaffray Overweight
Oct-05-16Upgrade Piper Jaffray Neutral → Overweight
Apr-26-16Downgrade Piper Jaffray Overweight → Neutral $6 → $1
Sep-30-14Reiterated ROTH Capital Buy $5 → $6
Sep-16-14Reiterated ROTH Capital Buy $3.50 → $5
Sep-15-14Reiterated H.C. Wainwright Buy $5 → $13
Oct-21-13Reiterated Aegis Capital Buy $4 → $5.50
Sep-24-13Initiated Maxim Group Buy $4
Sep-06-13Reiterated Aegis Capital Buy $3.50 → $4
Apr-18-13Initiated Aegis Capital Buy $2.50
Aug-27-12Upgrade Rodman & Renshaw Mkt Perform → Mkt Outperform $3.70
Oct-01-09Upgrade Merriman Sell → Neutral
May-29-09Downgrade Merriman Curhan Ford Buy → Sell
May-29-09Downgrade Hapoalim Neutral → Underperform
Dec-15-08Initiated Merriman Curhan Ford Buy
Nov-28-07Initiated Rodman & Renshaw Mkt Outperform $9
Jan-31-07Initiated Stifel Nicolaus Buy $9
Jan-05-07Initiated First Albany Buy $10
Sep-18-19 09:31AM  Buy These 7 Small Drugmakers to Boost Your Portfolio's Health Zacks
Sep-13-19 10:00AM  Catalyst Pharmaceutical (CPRX) is a Great Momentum Stock: Should You Buy? Zacks
08:41AM  Implied Volatility Surging for Catalyst (CPRX) Stock Options Zacks
07:40AM  The Daily Biotech Pulse: All Eyes On Aimmune, Ritter Stumbles In Late-Stage Study, Catalyst Shelves Offering Plans Benzinga
06:03AM  Catalyst Pharmaceuticals, Inc. Determines Not to Proceed with Previously Announced Public Offering of Common Stock GlobeNewswire
Sep-11-19 04:19PM  Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire +7.37%
Sep-10-19 03:18PM  Investors Can Find Big Returns with this First Profit Screen Zacks
Sep-06-19 09:48PM  Edited Transcript of CPRX earnings conference call or presentation 8-Aug-19 12:30pm GMT Thomson Reuters StreetEvents +5.60%
09:31AM  Why Is Catalyst (CPRX) Up 23% Since Last Earnings Report? Zacks
Aug-29-19 08:44AM  Catalyst Pharmaceuticals (CPRX) Looks Good: Stock Adds 6% in Session Zacks
Aug-28-19 08:03AM  Catalyst Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 4th, 2019 GlobeNewswire +5.99%
Aug-27-19 02:39PM  Here's How to Find Top-Ranked Stocks Under $10 to Buy Zacks
Aug-19-19 12:00PM  Top Ranked Momentum Stocks to Buy for August 19th Zacks
Aug-16-19 07:54AM  Will Catalyst Pharmaceuticals Continue to Surge Higher? Zacks +7.46%
Aug-13-19 11:42AM  Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX): The Best Of Both Worlds Simply Wall St. +6.00%
Aug-08-19 03:06PM  Why Catalyst Pharmaceuticals Stock Broke Down Today Motley Fool
09:26AM  Catalyst's (CPRX) Q2 Earnings and Revenues Beat Estimates Zacks
Aug-07-19 06:55PM  Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates Zacks
04:18PM  Catalyst Pharmaceuticals Announces Second Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
Aug-01-19 04:09PM  2 Small-Cap Stocks That Could Make You Rich Motley Fool
08:03AM  Catalyst Pharmaceuticals Announces Its Support of Spinal Muscular Atrophy Awareness Month GlobeNewswire
Jul-31-19 09:12AM  2 Top Stocks to Buy in August Motley Fool
08:03AM  Catalyst Pharmaceuticals to Hold Second Quarter 2019 Financial Results Conference Call and Webcast on Thursday, August 8th, 2019 GlobeNewswire
Jul-08-19 08:58AM  Do Directors Own Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Shares? Simply Wall St.
08:40AM  Do Options Traders Know Something About Catalyst (CPRX) Stock We Don't? Zacks
Jul-05-19 12:04PM  Catalyst Pharma Focuses on Firdapse Launch & Label Expansion Zacks
Jul-02-19 12:14PM  Explosive Stocks Under $10 Zacks
Jun-27-19 12:46PM  5 stocks trading at under $10 worth discovering MarketWatch
Jun-26-19 02:07PM  Here is What Hedge Funds Think About Catalyst Pharmaceuticals, Inc. (CPRX) Insider Monkey
Jun-25-19 08:37AM  Penny Stocks to Buy Using Technical Analysis for June 2019 Investopedia
Jun-13-19 05:46PM  Catalyst Pharma Files Lawsuit Against FDA Approval of Ruzurgi Zacks
Jun-12-19 09:46AM  UPDATE 2-Catalyst Pharma sues FDA over approval of cheaper rival drug Reuters
09:30AM  Catalyst (CPRX) Up 14.1% Since Last Earnings Report: Can It Continue? Zacks
09:00AM  Catalyst Pharma files lawsuit against U.S. FDA on Jacobus Pharma drug approval Reuters
08:47AM  Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration GlobeNewswire
Jun-04-19 08:03AM  Catalyst Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference GlobeNewswire
May-30-19 08:03AM  Catalyst Pharmaceuticals Announces Expansion of Firdapse License to Include Japan GlobeNewswire
May-29-19 12:08AM  Edited Transcript of CPRX earnings conference call or presentation 13-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-28-19 02:33PM  Catalyst Pharmaceuticals settles patent dispute with Northwestern University American City Business Journals
May-22-19 03:47PM  Catalyst Pharma (CPRX) Rides on Successful Launch of Firdapse Zacks -7.55%
May-18-19 07:15AM  5 Biotech Stocks to Watch in the Second Half of 2019 ETF Trends
May-16-19 11:00AM  Are These 2 Beaten-Down Biotech Stocks Worth the Risk? Motley Fool +6.21%
May-14-19 02:36PM  Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start Zacks
08:44AM  Implied Volatility Surging for Catalyst Pharmaceuticals (CPRX) Stock Options Zacks
May-13-19 02:00PM  Catalyst Pharmaceuticals Posts Strong Q1 Sales for Firdapse Motley Fool
01:10PM  Why Catalyst Pharmaceuticals Briefly Spiked Today Motley Fool
12:23PM  Catalyst Pharmaceuticals Inc (CPRX) Q1 2019 Earnings Call Transcript Motley Fool
07:35AM  Catalyst Pharmaceutical (CPRX) Reports Q1 Loss, Tops Revenue Estimates Zacks
06:27AM  Catalyst: 1Q Earnings Snapshot Associated Press
06:03AM  Catalyst Pharmaceuticals Announces First Quarter 2019 Financial Results and Provides Corporate Update GlobeNewswire
May-11-19 08:40AM  The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Benzinga
May-10-19 11:59AM  Why Catalyst Pharmaceuticals Stock Is Jumping Today Motley Fool +16.30%
11:11AM  Heres Why Analysts Remain Confident on Catalyst (CPRX) Stock SmarterAnalyst
May-07-19 12:08PM  Why Catalyst Pharmaceuticals Is Getting Crushed Today Motley Fool -39.61%
11:13AM  Biopharma Eyes Worst Day in Years on Rival's FDA Nod Schaeffer's Investment Research
11:10AM  Catalyst Pharma Plummets On Competition For Pricey LEMS Drug Benzinga
May-06-19 07:23PM  Catalyst Pharma stock plummets after FDA approves competitor's drug MarketWatch
08:03AM  Catalyst Pharmaceuticals to Hold First Quarter Financial Results Conference Call and Webcast on Monday, May 13th, 2019 GlobeNewswire
May-03-19 09:51AM  What's in Store for Catalyst Pharma (CPRX) Q1 Earnings? Zacks +6.69%
Apr-19-19 02:00PM  An Intrinsic Calculation For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Suggests It's 32% Undervalued Simply Wall St.
Apr-17-19 09:30AM  Catalyst (CPRX) Up 58.1% Since Last Earnings Report: Can It Continue? Zacks
Apr-04-19 10:24AM  Why Catalyst Pharmaceuticals, Inc. Soared in March Motley Fool
Mar-31-19 09:00AM  3 Top Biotech Stocks to Buy Right Now Motley Fool
Mar-25-19 06:20PM  Edited Transcript of CPRX earnings conference call or presentation 19-Mar-19 12:30pm GMT Thomson Reuters StreetEvents +30.35%
08:09AM  2 High-Growth Stocks I'd Buy Right Now Motley Fool
Mar-19-19 05:23PM  Why Catalyst Pharmaceuticals Stock Is Popping Today Motley Fool +12.99%
02:26PM  Catalyst (CPRX) Reports Wider Q4 Loss, Focuses on Firdapse Zacks
07:40AM  The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed Benzinga
Mar-18-19 04:52PM  Catalyst: 4Q Earnings Snapshot Associated Press
04:20PM  Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update GlobeNewswire
Mar-14-19 01:34PM  The Catalyst Pharmaceuticals (NASDAQ:CPRX) Share Price Has Gained 181%, So Why Not Pay It Some Attention? Simply Wall St.
Mar-11-19 08:03AM  Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 19th, 2019 GlobeNewswire
Feb-28-19 01:44PM  U.S. Senator Sanders urges FDA to allow older versions of $375,000 drug Reuters -5.83%
08:03AM  Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2019 GlobeNewswire
07:00AM  U.S. Senator Sanders urges FDA to allow older versions of $375K drug Reuters
Feb-26-19 08:03AM  Catalyst Pharmaceuticals Announces Publication of Phase 3 Clinical Trial Data for Firdapse® for the Treatment of Lambert-Eaton Myasthenic Syndrome GlobeNewswire +5.90%
Feb-21-19 02:28PM  Catalyst Pharmaceuticals defends $375,000 drug price after Bernie Sanders rebuke Reuters
09:23AM  Catalyst defends drug price after Bernie Sanders' rebuke Reuters
09:00AM  Catalyst Pharmaceuticals Responds to Letter from Senator Bernie Sanders GlobeNewswire
Feb-11-19 02:58PM  Catalyst Pharma sees net price of drug, once free, topping $300,000 Reuters
Feb-06-19 02:39PM  Coral Gables company under fire for drug pricing says patient care is 'top priority' American City Business Journals
Feb-05-19 08:03AM  Catalyst Pharmaceuticals to Present at the 21st Annual BIO CEO & Investor Conference GlobeNewswire
Feb-04-19 10:34AM  U.S. Senator Sanders asks why drug, once free, now costs $375k Reuters -5.58%
06:00AM  U.S. Senator Sanders to ask why drug, once free, now costs $375k Reuters
Jan-28-19 12:22PM  What Kind Of Shareholders Own Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)? Simply Wall St.
Jan-04-19 08:03AM  Catalyst Pharmaceuticals Announces Publication of Clinical Data from the Investigator-Sponsored Phase IIb Study Evaluating Firdapse® for the Treatment of MuSK Antibody Positive Myasthenia Gravis GlobeNewswire +5.99%
Dec-19-18 12:32PM  Should You Buy Catalyst Pharmaceuticals, Inc. (CPRX)? Insider Monkey -7.82%
Dec-18-18 11:40AM  Catalyst Pharmaceuticals Announces Definitive Agreement with Endo for Vigabatrin Tablets GlobeNewswire
Dec-14-18 11:42AM  Does Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Have A Volatile Share Price? Simply Wall St.
Dec-11-18 07:30AM  Report: Exploring Fundamental Drivers Behind Sabre, Catalyst Pharmaceuticals, Renewable Energy Group, Luminex, Parker Drilling, and Apollo Endosurgery New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire +5.53%
Dec-03-18 08:03AM  Catalyst Pharmaceuticals Announces Conference Call to Discuss Commercialization Plan for Firdapse® (amifampridine) for Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire -5.92%
Nov-30-18 05:42PM  Why Catalyst Pharmaceuticals Stock Fell Again Today Motley Fool -8.48%
Nov-29-18 04:00PM  Why Catalyst Pharmaceuticals Stock Is Sinking Today Motley Fool -11.50%
09:25AM  FDA approves new drug developed by Coral Gables company American City Business Journals
08:33AM  Catalyst's Firdapse Receives FDA Approval for Rare Disease Zacks
06:50AM  Today's Research Reports on Trending Tickers: Alliqua BioMedical and Catalyst Pharmaceuticals ACCESSWIRE
06:03AM  FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) GlobeNewswire
Nov-28-18 06:36PM  U.S. FDA approves Catalyst Pharma's rare disease drug Reuters +7.56%
Nov-27-18 04:12PM  Catalyst Pharmaceuticals Announces Firdapse® (amifampridine) New Drug Application Continues Under Review GlobeNewswire
Nov-20-18 09:52PM  Edited Transcript of CPRX earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents -5.74%
Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with lambert-eaton myasthenic syndrome in the United States. The company also develops Firdapse, which is in various clinical trials for the treatment of patients with congenital myasthenic syndrome, anti-MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3. It has license agreements with New York University, the Feinstein Institute for Medical Research, and BioMarin Pharmaceutical Inc.; and collaboration agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCENANY PATRICK JPresident and CEOJun 11Buy3.2325,00080,7504,762,693Jun 11 02:06 PM
DENKHAUS DONALD ADirectorDec 27Buy1.9125,00047,750225,000Dec 28 12:29 PM
MCENANY PATRICK JPresident and CEODec 19Buy2.2420,00044,8004,737,693Dec 19 04:25 PM
DENKHAUS DONALD ADirectorDec 14Buy2.4860,000148,800200,000Dec 17 04:19 PM
O'Keeffe Charles BDirectorDec 14Buy2.5020,00050,000543,376Dec 14 04:50 PM